Lithuanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
ambrosia/hypersensitivity
Nuoroda įrašoma į mainų sritį
Puslapis 1 nuo 31 rezultatus
HAL-MRE1 Subcutaneous Immunotherapy in Ragweed Allergic Patients First-in-human
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
A chemically modified, aluminum hydroxide adsorbed ragweed extract (HAL-MRE1) for subcutaneous administration was developed for the treatment of ragweed pollen-induced allergic rhinitis/rhinoconjunctivitis (ARC) with or without asthma. The aim of this first-in-human phase I study is to assess the
Desensitization and Cross-Desensitization During Oral Grass or Ragweed Pollen Immunotherapy
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
To induce clinical tolerance, a failure to respond to an allergen to which one was previously responsive, is an important objective for physicians, one that plays a significant role in the primary prevention of allergic reactions in the clinical practice of Allergy & Immunology. The tolerance
Efficacy and Safety Study of RAGWITEK™ (MK-3641) in Children With Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (MK-3641-008)
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Safety Study of Ragweed-SPIRE in Subjects With Ragweed Allergies and Asthma
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Evaluating the Efficacy of Ragweed-SPIRE Following Exposure to Ragweed Allergen in an Environmental Exposure Chamber
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
The Significance of Ambrosia in Allergic Rhinitis and Asthma in Israel
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
A Study of Ragweed (Ambrosia Artemisiifolia) Allergy Immunotherapy Tablet in Adults With Ragweed Allergies (P05751)
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
ToleroMune Ragweed Follow up Study
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Subjects who were randomised in study TR002 and who completed all dosing visits and the PTC will be invited to attend the Screening Visit for TR002B. Subjects will attend the EEC for 4 visits on successive days. Following the final EEC visit a follow-up visit will be performed 3-10 days later.
Allergenic Effect of Ambrosia in Israel
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Identification of Potential Biomarkers of Response to Peptide Immunotherapy for Ragweed Allergy
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
A Study to Evaluate the Safety and Efficacy of the QLT Proprietary Olopatadine-PPDS in Subjects With Seasonal Allergic Conjunctivitis to Ragweed in an Environmental Exposure Chamber Model.
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Safety and Tolerability Study of Ragweed SLIT Tablets
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
ToleroMune Ragweed Exposure Chamber Study
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
This study is designed as a randomised, double-blind, placebo-controlled, parallel group study to evaluate the safety and tolerability of ToleroMune Ragweed in ragweed allergic subjects with allergic rhinoconjunctivitis,subjects may also have controlled asthma. The efficacy of ToleroMune Ragweed
A Single-Center Evaluation of the Pattern of Allergic Signs and Symptoms During 4 Weeks in Ragweed Season
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Subjects who had a positive skin test to ragweed within 24 months of Visit 1 were instructed to complete a diary, which assessed their allergic signs and symptoms 3 times a day for 4 weeks. During the in-office visits, subjects were asked to completed a quality of life questionnaire, as well as a
Safety Study of Ragweed Allergy Immunotherapy Tablet in Subjects 50 Years of Age and Older (Study P06081)
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
Išsamiausia vaistinių žolelių duomenų bazė, paremta mokslu
- Dirba 55 kalbomis
- Žolelių gydymas, paremtas mokslu
- Vaistažolių atpažinimas pagal vaizdą
- Interaktyvus GPS žemėlapis - pažymėkite vaistažoles vietoje (netrukus)
- Skaitykite mokslines publikacijas, susijusias su jūsų paieška
- Ieškokite vaistinių žolelių pagal jų poveikį
- Susitvarkykite savo interesus ir sekite naujienas, klinikinius tyrimus ir patentus
Įveskite simptomą ar ligą ir perskaitykite apie žoleles, kurios gali padėti, įveskite žolę ir pamatykite ligas bei simptomus, nuo kurių ji naudojama.
* Visa informacija pagrįsta paskelbtais moksliniais tyrimais
